IMR

cover
醫療設備開發商Imricor發出季度報告,三大市場擴展策略全力推進

磁共振引導心臟消融產品的全球領導者Imricor Medical Systems (ASX:IMR) 今日發布其截至2021年6月30日的季度現金流報告並提供財務和運營業績的季度更新。季度內,該公司新增一個新站點——Helios Hospital Berlin-Buch。公司表示,雖然其分銷管道仍然強勁,但由於冠狀病毒病 (COVID-19) 帶來的長期影響,以及6月和7月的接種率低於預期,新iCMR站點的合同簽署進度比預期要慢。

cover
心臟消融設備公司Imricor簽署其第十個iCMR實驗室站點

可視化心臟消融設備公司Imricor Medical Systems,Inc.( ASX:IMR)宣布,已與德國柏林布赫Helios綜合性醫院(Helios Hospital Berlin-Buch)簽署協議,成為第十個建立iCMR(介入性心臟磁共振成像)實驗室的臨床站點,將采用Imricor的產品在由MRI引導的環境下進行可視化的心臟消融手術。

cover
脫水簡報- Imricor Medical Systems個股分析

Imricor Medical Systems,Inc. (ASX:IMR)是一家位於美國的醫療設備公司。該公司專注於設計,制造和銷售與磁共振成像(MRI)兼容的產品,這些產品可用於治療心律失常的心臟導管消融手術。

cover
Imricor signed distribution agreement to facilitate sales in Australia and NZ

Imricor Medical Systems (ASX: IMR) signed a Distribution Agreement with Sydney-based medical device distributor Regional Health Care Group Pty Ltd (RGCH). Pursuant to the agreement, RHCG will be the exclusive distributor of Imicor's consumable products in Australia and New Zealand, and a non-exclusive distributor of Imicor's capital equipment.

cover
心臟消融手術設備提供商IMR和澳新醫療設備分商RHCG簽署協議

醫療設備公司Imricor Medical Systems (ASX: IMR)與悉尼醫療產品分銷公司Regional Health Care Group Pty Ltd簽訂產品分銷協議。根據協議,RHCG成為Imricor消耗品(訂閱產品)的獨家分銷商,以及Imricor核心設備的澳洲和新西蘭非獨家分銷商。此外,RGCH還將幫助Imricor產品在澳大利亞和新西蘭獲得必要的監管批準,團隊預計將於2021年底獲得首批批準。

cover
Imricor benefits as elective surgery resumed in German

Imricor Medical Systems (ASX: IMR), an ASX-listed global cardia ablation product producer, has announced today that one of its collaboration partners in Europe, the Helios Leipzig Heart Centre, has resumed elective surgery.